Loi M - Search Results

1

Locoregional control and survival after lymph node SBRT in oligometastatic disease.

Loi M, Frelinghuysen M, Klass ND, Oomen-De Hoop E, Granton PV, Aerts J, Verhoef C, Nuyttens J. Loi M, et al. Clin Exp Metastasis. 2018 Oct;35(7):625-633. doi: 10.1007/s10585-018-9922-x. Epub 2018 Jul 11. Clin Exp Metastasis. 2018. PMID: 29995254 Free PMC article.

2

Robotic stereotactic treatment for malignant metastasis of solid tumour in the pancreas: A multiple case report and review of literature.

Loi M, Magallon-Baro A, Papalazarou C, Milder M, Nuyttens JJ. Loi M, et al. Cancer Radiother. 2017 Dec;21(8):784-787. doi: 10.1016/j.canrad.2017.06.012. Epub 2017 Nov 11. Cancer Radiother. 2017. PMID: 29132801 Review.

3

Prognostic impact of nodal relapse in definitive prostate-only irradiation.

Loi M, Incrocci L, Desideri I, Bonomo P, Detti B, Simontacchi G, Greto D, Olmetto E, Francolini G, Meattini I, Livi L. Loi M, et al. Radiol Med. 2018 Aug;123(8):631-637. doi: 10.1007/s11547-018-0888-1. Epub 2018 Apr 12. Radiol Med. 2018. PMID: 29651712

4

Stereotactic body radiotherapy for oligometastatic soft tissue sarcoma.

Loi M, Duijm M, Baker S, Rossi L, Grunhagen D, Verhoef C, Nuyttens J. Loi M, et al. Radiol Med. 2018 Nov;123(11):871-878. doi: 10.1007/s11547-018-0912-5. Epub 2018 Jun 19. Radiol Med. 2018. PMID: 29923086

5

Pain flare, complexity and analgesia in bone oligometastases treated with stereotactic body radiation therapy.

Loi M, Klass ND, De Vries KC, Fleury E, Van Zwienen M, de Pree I, Nuyttens J. Loi M, et al. Eur J Cancer Care (Engl). 2018 Nov;27(6):e12915. doi: 10.1111/ecc.12915. Epub 2018 Sep 24. Eur J Cancer Care (Engl). 2018. PMID: 30246916

6

Modeling daily changes in organ-at-risk anatomy in a cohort of pancreatic cancer patients.

Magallon-Baro A, Loi M, Milder MTW, Granton PV, Zolnay AG, Nuyttens JJ, Hoogeman MS. Magallon-Baro A, et al. Among authors: loi m. Radiother Oncol. 2019 May;134:127-134. doi: 10.1016/j.radonc.2019.01.030. Epub 2019 Feb 8. Radiother Oncol. 2019. PMID: 31005206

7

Pancreatic cancer treated with SBRT: Effect of anatomical interfraction variations on dose to organs at risk.

Loi M, Magallon-Baro A, Suker M, van Eijck C, Sharma A, Hoogeman M, Nuyttens J. Loi M, et al. Radiother Oncol. 2019 May;134:67-73. doi: 10.1016/j.radonc.2019.01.020. Epub 2019 Feb 2. Radiother Oncol. 2019. PMID: 31005226

8

A model-based patient selection tool to identify who may be at risk of exceeding dose tolerances during pancreatic SBRT.

Magallon-Baro A, Granton PV, Milder MTW, Loi M, Zolnay AG, Nuyttens JJ, Hoogeman MS. Magallon-Baro A, et al. Among authors: loi m. Radiother Oncol. 2019 Dec;141:116-122. doi: 10.1016/j.radonc.2019.09.016. Epub 2019 Oct 9. Radiother Oncol. 2019. PMID: 31606227

9

Single-Fraction Radiotherapy (SFRT) For Bone Metastases: Patient Selection And Perspectives.

Loi M, Nuyttens JJ, Desideri I, Greto D, Livi L. Loi M, et al. Cancer Manag Res. 2019 Nov 5;11:9397-9408. doi: 10.2147/CMAR.S186630. eCollection 2019. Cancer Manag Res. 2019. PMID: 31807069 Free PMC article. Review.

10

Two cases of Hemosuccus pancreaticus after stereotactic radiotherapy to the pancreas: A case study.

Pezzulla D, Loi M, Suker M, van Eijck C, Nuyttens J. Pezzulla D, et al. Among authors: loi m. Cancer Radiother. 2020 Feb;24(1):60-63. doi: 10.1016/j.canrad.2019.09.003. Epub 2020 Jan 21. Cancer Radiother. 2020. PMID: 31980360

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

444 results

Search Page

Filters